Merck & Co traded at $92.42 this Friday July 1st, increasing $1.25 or 1.37 percent since the previous trading session. Looking back, over the last four weeks, Merck & Co gained 2.69 percent. Over the last 12 months, its price rose by 17.58 percent. Looking ahead, we forecast Merck & Co to be priced at 90.62 by the end of this quarter and at 83.51 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
92.42
Daily Change
1.37%
Yearly
17.58%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.80 0.64 0.42% 33.54%
Abbott 110.22 1.57 1.45% -6.62%
ALKERMES 30.53 0.74 2.48% 20.67%
Amgen 245.55 2.25 0.92% -1.27%
AstraZeneca 10,754.00 -46.00 -0.43% 22.50%
Astrazeneca 65.95 -0.12 -0.18% 8.49%
Biogen 210.63 6.69 3.28% -39.60%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Coherus Biosciences 7.83 0.59 8.15% -42.97%
Catalent 107.02 -0.27 -0.25% -3.69%
Endo International 0.57 0.10 22.42% -86.74%
Gilead Sciences 62.36 0.55 0.89% -10.01%
GlaxoSmithKline 1,785.60 20.00 1.13% 24.19%
Glaxosmithkline 43.75 0.22 0.51% 8.27%
Horizon Pharma 80.84 1.08 1.35% -15.68%
Intercept Pharmaceuticals 14.13 0.32 2.32% -29.31%
Jazz Pharmaceuticals 158.58 2.57 1.65% -12.63%
J&J 179.52 2.01 1.13% 6.24%
Eli Lilly 324.71 0.48 0.15% 38.79%
Medtronic 91.38 1.63 1.82% -27.95%
Merck & Co 92.42 1.25 1.37% 17.58%
Novartis 80.33 -0.52 -0.64% -4.96%
Novartis 84.36 -0.17 -0.20% -8.28%
Phibro Animal Health 19.59 0.46 2.40% -33.68%
Prestige Brands 59.58 0.78 1.33% 14.14%
Pacira 57.85 -0.45 -0.77% -2.41%
Pfizer 52.31 -0.12 -0.23% 31.66%
Perrigo 41.02 0.45 1.11% -12.56%
Drreddys Laboratories 55.84 0.45 0.81% -25.83%
Regeneron Pharmaceuticals 595.40 4.27 0.72% 2.01%
Roche Holding 320.40 1.85 0.58% -8.34%
Revance Therapeutics 14.33 0.51 3.69% -52.85%
Sanofi 97.52 1.18 1.22% 10.94%
Sanofi 51.01 0.98 1.96% -2.60%
Teva Pharmaceutical Industries 7.89 0.37 4.92% -19.74%
United Therapeutics 238.00 2.36 1.00% 29.12%
Zoetis 174.21 2.32 1.35% -9.60%

Indexes Price Day Year
US500 3825 39.95 1.06% -12.11%
US30 31097 321.83 1.05% -10.61%

Merck & Co
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.